Milica Medved to Carcinoma, Renal Cell
This is a "connection" page, showing publications Milica Medved has written about Carcinoma, Renal Cell.
Connection Strength
0.058
-
Dynamic contrast-enhanced magnetic resonance imaging pharmacodynamic biomarker study of sorafenib in metastatic renal carcinoma. J Clin Oncol. 2008 Oct 01; 26(28):4572-8.
Score: 0.058